Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.5803
Delayed Data
As of Jul 31
 -0.0097 / -1.64%
Today’s Change
0.42
Today|||52-Week Range
1.30
-7.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues123.0K152.0K491.0K538.0K
 
 
 
 
 
Cost of Goods Sold18.0K20.0K249.0K107.0K
 
 
 
 
 
Depreciation And Amortization71.0K44.0K47.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income34.0K88.0K195.0K390.0K
 
 
 
 
 
General Expenses3.8M4.2M5.1M5.1M
 
 
 
 
 
Research And Development2.2M2.3M2.4M1.6M
 
 
 
 
 
Total Operating Expenses3.9M4.3M5.4M5.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.8M-4.1M-4.9M-4.7M
 
 
 
 
 
Extraordinary Credit797.0K--451.0K34.0K
 
 
 
 
Extraordinary Charge---104.0K0.00--
 
 
Other Expenses57.0K-2.0K-26.0K-11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.9M-4.2M-4.5M-4.6M
 
 
 
 
 
Income Taxes-10.0K0.00-8.0K-2.0K
 
 
 
 
Net Income-2.9M-4.2M-4.5M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.8M50.8M51.5M54.4M
 
 
 
 
 
Shares To Calculate EPS Diluted50.8M50.8M51.5M54.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.08-$0.09-$0.09
 
 
 
 
 
EPS Diluted-$0.06-$0.08-$0.09-$0.09